Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015618
Filing Date
2025-06-04
Accepted
2025-06-04 17:47:00
Documents
1
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 form4-06042025_090657.html 4  
1 form4-06042025_090657.xml 4 7529
  Complete submission text file 0001415889-25-015618.txt   9100
Mailing Address C/O PELOTON THERAPEUTICS, INC. 2330 INWOOD ROAD, SUITE 226 DALLAS TX 75235
Business Address
Josey John A. (Reporting) CIK: 0001776351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 251024297

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)